Showing results (131-140 of 138) with videos related to
Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 138 results.
Frontiers in Cellular and Infection Microbiology|March 22, 2021
Repeat-Driven Generation of Antigenic Diversity in a Major Human Pathogen, Trypanosoma cruziCarlos Talavera-López, Louisa A Messenger, Michael D Lewis, et al.Emerging Infectious Diseases|February 27, 2023
Monitoring Temporal Changes in SARS-CoV-2 Spike Antibody Levels and Variant-Specific Risk for Infection, Dominican Republic, March 2021-August 2022Eric J Nilles, Michael de St Aubin, Devan Dumas, et al.The American Journal of Tropical Medicine and Hygiene|June 3, 2025
Characteristics of Hand Hygiene Adherence in Selected Healthcare Settings in Latin America and East Africa as Part of COVID-19 Response Efforts, 2020-2021Denisse Vega Ocasio, David Berendes, Zainab Salah, et al.Medrxiv : the Preprint Server for Health Sciences|September 15, 2025
Autoantibodies neutralizing type I IFNs in 40% of patients with WNV encephalitis in seven new cohortsAdrian Gervais, Francesca Trespidi, Alessandro Ferrari, et al.Journal of Human Immunity|March 16, 2026
Autoantibodies neutralizing type I IFNs in 40% of patients with WNV encephalitis in seven new cohortsAdrian Gervais, Francesca Trespidi, Alessandro Ferrari, et al.PLOS Water|February 27, 2024
Improving water, sanitation, and hygiene (WASH), with a focus on hand hygiene, globally for community mitigation of COVID-19David Berendes, Andrea Martinsen, Matt Lozier, et al.Emerging Infectious Diseases|December 11, 2022
Incorporating COVID-19 into Acute Febrile Illness Surveillance Systems, Belize, Kenya, Ethiopia, Peru, and Liberia, 2020-2021David C Shih, Rachel Silver, Olga L Henao, et al.The Journal of Experimental Medicine|June 22, 2023
Autoantibodies neutralizing type I IFNs underlie West Nile virus encephalitis in ∼40% of patientsAdrian Gervais, Francesca Rovida, Maria Antonietta Avanzini, et al.Pageof 14